Urinary Retinol-Binding Protein as a Prognostic Marker in Glomerulopathies

Publisher： Karger

E-ISSN： 2235-3186|90|4|424-431

ISSN： 1660-8151

Source： Nephron, Vol.90, Iss.4, 2002-04, pp. : 424-431

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Urinary Retinol-Binding Protein as a Prognostic Marker in the Treatment of Nephrotic Syndrome

By  

Nephron, Vol. 86, Iss. 2, 2000-09 ,pp. : 109-114

Karger

Access to resources Recommend Favorite

Urinary Excretion of Monocyte Chemoattractant Protein-1: A Biomarker of Active Tubulointerstitial Damage in Patients with Glomerulopathies

By  

Kidney and Blood Pressure Research, Vol. 30, Iss. 5, 2007-09 ,pp. : 306-313

Karger

Access to resources Recommend Favorite

Significance of Glomerular Deposition of Protein S in Various Glomerulopathies

By  

Nephron, Vol. 78, Iss. 1, 1997-12 ,pp. : 38-43

Karger

Access to resources Recommend Favorite

Urinary Liver-Type Fatty Acid-Binding Protein: Discrimination between IgA Nephropathy and Thin Basement Membrane Nephropathy

By  

American Journal of Nephrology, Vol. 25, Iss. 5, 2005-10 ,pp. : 447-450

Karger

Access to resources Recommend Favorite

Effect of Pitavastatin on Urinary Liver-Type Fatty-Acid-Binding Protein in Patients with Nondiabetic Mild Chronic Kidney Disease

By  

American Journal of Nephrology, Vol. 26, Iss. 1, 2006-04 ,pp. : 82-86

Karger

Access to resources Recommend Favorite